Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)
Winter Park, Florida--(Newsfile Corp. - May 5, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company based in Winter Park, Florida, dedicated to advancing regenerative therapies for chronic diseases, today announced that its pivotal clinical study on kidney disease has received Institutional Review Board (IRB) approval and has been successfully submitted to ClinicalTrials.gov.
Healthcare and Hospitals, Health
2026-05-05 10:08 AM EDT | Adia Nutrition Inc.
Tersis Technologies Appoints Energy Infrastructure Expert Michael W. Stogner as Strategic Advisor to Accelerate Deployment of SynGenic V3 Platform
Brooksville, Florida--(Newsfile Corp. - May 5, 2026) - Tersis Technologies, Inc. (OTCID: TERS) ("Tersis" or the "Company"), a circular economy technology company focused on converting waste streams into energy and valuable byproducts, today announced the appointment of Michael W. Stogner as Strategic Advisor - Energy Infrastructure, Deployment & Fuel Strategy.
Agriculture, Energy, Alternative Energy, Health
2026-05-05 10:00 AM EDT | Tersis Technologies Inc.
Breathe BioMedical Expands Multi-Center Clinical Study in Breast Cancer to Pittsburgh
New Brunswick and Cambridge, Massachusetts--(Newsfile Corp. - May 5, 2026) - Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced the addition of Weinstein Imaging Associates in Pittsburgh, Pennsylvania as a new clinical site in its large multi-center observational collection protocol study to advanc
Technology, Biotechnology, Healthcare and Hospitals, Health
2026-05-05 9:00 AM EDT | Breathe BioMedical Inc.
Altrova Health Announces Launch of O-Spray Product Line and Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: SSPLF) (FSE: QM4) ("Altrova Health" or the "Company") today announced the introduction of O-Spray™, a needle-free sublingual oral spray dosage format designed as an alternative to self-injection, pill, and syringe-based administration. O-Spray is positioned across current and future therapeutic areas including weight management, erectile dysfunction, menopause-related care, and other
2026-05-05 7:04 AM EDT | Altrova Health Inc.
Promino Responds to Growing Demand for Muscle Health Support as Health Canada Expands Access to Semaglutide
Burlington, Ontario--(Newsfile Corp. - May 5, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company"), a performance nutrition co
Food / Beverages, Sports, Health
2026-05-05 7:00 AM EDT | Promino Nutritional Sciences, Inc.
Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets
Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced medical device technologies, is pleased to announce that Horizon Health ("Horizon") has purchased an additional 100 Venowave™ units. This second commercial order follows the rapid deployment and clinical success of the initial 100-unit shipment delivered to Horizon in la
Technology, Biotechnology, Health
2026-05-05 6:30 AM EDT | Therma Bright Inc.
Restart Life Sciences Reports Holy Crap Foods Revenue Gains of 46% in Wholesale and 32% via Amazon Channels YoY
Vancouver, British Columbia--(Newsfile Corp. - May 5, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to report a significant revenue milestone for April 2026, marking a period of substantial growth following the integration of Holy Crap Foods Inc. Since completing the acquisition on February 27, 2026, the Company has executed a strategic roadmap focused on stabilizing operations, optimizing channel efficiency, a
Technology, Biotechnology, Health
2026-05-05 6:00 AM EDT | Restart Life Sciences Corp.
Scryb Inc. Changes Name to NorthPalm Capital Corp. and Announces New Trading Symbols
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - NorthPalm Capital Corp. (CSE: NP) ("NorthPalm Capital" or the "Company") (formerly, Scryb Inc.), is pleased to announce that further to its news release dated April 15, 2026, the Company's common shares will commence trading on the Canadian Securities Exchange under the new name, "NorthPalm Capital Corp." effective at the market open on May 7, 2026 (the "Name Change") and the trading symbol for the Company will cha
Biotechnology, Healthcare and Hospitals, Health
2026-05-04 9:41 PM EDT | NorthPalm Capital Corp.
Mobile-health Network Solutions Enters into Non-Binding US$119 Million Strategic Framework with Hector Capital to Acquire BIMA and M&M Helix, Accelerating AI-powered Healthcare Expansion across Asia and Africa
Singapore, Singapore--(Newsfile Corp. - May 4, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced the signing of a non-binding Strategic Cooperation Framework Memorandum of Understanding ("MOU") with Hector Capital Holdings Pte. Ltd. ("Hector Capital"). Under the framework, Hector Capital will invest up to US$119 million into MNDR to support the acquisition of majority shareholdings in MILVI
2026-05-04 9:16 AM EDT | Mobile-health Network Solutions
DiagnosTear Technologies Inc. Announces Warrant Extension
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company") announces that it has extended the expiry date of 5,733,885 outstanding common share purchase warrants (the "November 2024 Warrants") and 133,333 outstanding common share purchase warrants (the "December 2024 Warrants"). The November 2024 Warrants were issued in connection with a non-brokered private placement of subscription r
2026-05-04 8:30 AM EDT | DiagnosTear Technologies Inc.
Red Light Holland Announces Intention to Rebrand
New name and branding to be announced in the coming weeks, better aligned with the Company's scientific mandate and all business segments Name change resolution to be voted on by shareholders at the upcoming Annual General and Special Meeting ("AGSM") on May 11, 2026 Company urges all shareholders to vote IN FAVOUR of the name change resolution to support the rebranding exercise Rebranding reflects the combined focus on clinical research, GMP
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-05-04 8:30 AM EDT | Red Light Holland Corp.
QScreen AI Reports Internal Validation Results for Correctional Intake Platform: 100% Sensitivity on Suicide Risk and Withdrawal Detection Across 65 Calibrated Clinical Scenarios
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening today reports internal validation results for its correctional intake platform across 65 calibrated clinical scenarios tested against published instrument thresholds. By digitizing the high-liability blind spots of correctional intake, QAI transforms a universal institutional risk into a scalable Saa
2026-05-04 7:03 AM EDT | QScreen AI Inc.
Promino Nutritional Sciences Reports Fiscal 2025 Results, Delivering Revenue Growth and Improved Financial Performance
Burlington, Ontario--(Newsfile Corp. - May 4, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company"), a performance nutrition company focused on clinically validated amino acid formulations, today announced its audited financial results for the year ended December 31, 2025. Fiscal 2025 Financial Highlights Revenue of over $2.1 million, compared to approximately $260,600 in 2024
Food / Beverages, Sports, Health
2026-05-04 7:00 AM EDT | Promino Nutritional Sciences, Inc.
Neural Therapeutics Announces Filing and Mailing of Meeting Materials for Annual and Special Meeting to Approve Series B Transactions with CWE
Toronto, Ontario--(Newsfile Corp. - May 1, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for mental health conditions related to substance use disorders, announces that it has filed on SEDAR+ and completed the mailing of its notice of annual and special meeting, management information circular and related meeting materials (collectively, the "Mee
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-05-01 8:04 AM EDT | Neural Therapeutics Inc.
Three Finalists Announced for the 2026 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - May 1, 2026) - Bloom Burton & Co. ("Bloom Burton") is thrilled to announce the finalists for the 2026 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The finalists for 2026, in alphabetical order, are: Ian Mortimer, President & Chief Executive Officer, Xenon Ph
Technology, Biotechnology, Investment Banking, Health
2026-05-01 7:30 AM EDT | Bloom Burton & Co. Inc.
Edison Issues Report on Abcourt Mines (ABI)
London, United Kingdom--(Newsfile Corp. - May 1, 2026) - Edison issues report on Abcourt Mines (TSXV: ABI). Abcourt Mines is in the process of ramping up its Sleeping Giant mine in the Abitibi region of Quebec. To date, this ramp up has been exclusively focused on room-and-pillar stopes. However, Abcourt commissioned its first long-hole stope this month and expects it to be in production in early summer, after which the pace of ramp up should increase materially, allowing the mine to ac
Banking / Financial Services, Computer Hardware, Computer Software, Health
2026-05-01 7:11 AM EDT | Edison Group
Safe Supply Streaming Co Ltd. Completes Rebranding to Altrova Health Inc., with Common Shares Now Trading Under New Ticker Symbol ROVA on the CSE
Toronto, Ontario--(Newsfile Corp. - May 1, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: SSPLF) (FSE: QM4) (formerly Safe Supply Streaming Co Ltd.) ("Altrova Health" or the "Company") announces the completion of its corporate rebranding and the commencement of trading of its common shares under the new name and ticker symbol "ROVA" on the Canadian Securities Exchange ("CSE"), effective today. Corporate Name and Ticker Change The name and ticker c
2026-05-01 7:07 AM EDT | Altrova Health Inc.
Beckett's Secures US$500,000 in Convertible Debenture Financing and Files 2025 Fiscal Year-End Results
Ontario and Los Angeles, California--(Newsfile Corp. - May 1, 2026) - Beckett's Inc. (CSE: BKTS) ("Beckett's" or the "Company") announces that it intends to complete a secured debt financing raising gross proceeds of US$500,000 by way of issuance of 5-Year 8% Secured Convertible Debentures (the "Debentures"). The principal amount of the Debentures will bear interest at a rate of 8% per annum and will have a term of five (5) years. Subject to regulatory ap
Food / Beverages, Cannabis, Health
2026-05-01 7:00 AM EDT | Becketts Inc.
Dr. Christina Rahm Recognized Nationally for Building Patent-Driven Manufacturing Behind The ROOT Brands Products
Franklin, Tennessee--(Newsfile Corp. - April 30, 2026) - Dr. Christina Rahm, scientist, inventor, and Founder and Chief Science Officer of The ROOT Brands, has received a Gold Stevie® Award in the 2026 American Business Awards® for Building and Scaling Patent-Driven Manufacturing Infrastructure (M
Biotechnology, Food / Beverages, Health
2026-04-30 4:45 PM EDT | DRC Ventures
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its proprietary Botanical Synthesis™ platform, today announced that it will report its first quarter 2026 financial results before the market opening on Thursday, May 14, 2026. The Company will also host a conference call and webcast at 8:00 a.m. U.S. Eastern Time to discuss the results and provide
Biotechnology, Pharmaceuticals, Health
2026-04-30 4:05 PM EDT | BioHarvest Sciences Inc.